Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3

OBJECTIVE: This analysis evaluated efficacy and safety of filgotinib, a Janus-associated kinase 1-preferential inhibitor, in methotrexate (MTX)-naive patients with rheumatoid arthritis (RA) with multiple poor prognostic factors (PPFs). METHODS: This was a post hoc analysis of the phase III, randomis...

Descripción completa

Detalles Bibliográficos
Autores principales: Aletaha, Daniel, Westhovens, René, Gaujoux-Viala, Cecile, Adami, Giovanni, Matsumoto, Alan, Bird, Paul, Messina, Osvaldo Daniel, Buch, Maya H, Bartok, Beatrix, Yin, Zhaoyu, Guo, Ying, Hendrikx, Thijs, Burmester, Gerd R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362717/
https://www.ncbi.nlm.nih.gov/pubmed/34385364
http://dx.doi.org/10.1136/rmdopen-2021-001621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362717/
https://www.ncbi.nlm.nih.gov/pubmed/34385364
http://dx.doi.org/10.1136/rmdopen-2021-001621

Ejemplares similares